SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016267
Filing Date
2022-11-03
Accepted
2022-11-03 16:25:43
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20220930x10q.htm   iXBRL 10-Q 1192813
2 EX-10.1 gbio-20220930xex10d1.htm EX-10.1 192958
3 EX-31.1 gbio-20220930xex31d1.htm EX-31.1 7627
4 EX-31.2 gbio-20220930xex31d2.htm EX-31.2 8144
5 EX-32.1 gbio-20220930xex32d1.htm EX-32.1 5121
6 EX-32.2 gbio-20220930xex32d2.htm EX-32.2 5100
7 GRAPHIC gbio-20220930xex10d1001.jpg GRAPHIC 683
8 GRAPHIC gbio-20220930xex10d1003.jpg GRAPHIC 11875
  Complete submission text file 0001558370-22-016267.txt   4284156

Data Files

Seq Description Document Type Size
9 EX-101.SCH gbio-20220930.xsd EX-101.SCH 24612
10 EX-101.CAL gbio-20220930_cal.xml EX-101.CAL 34266
11 EX-101.DEF gbio-20220930_def.xml EX-101.DEF 100317
12 EX-101.LAB gbio-20220930_lab.xml EX-101.LAB 222874
13 EX-101.PRE gbio-20220930_pre.xml EX-101.PRE 190882
47 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20220930x10q_htm.xml XML 573175
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 221358441
SIC: 2834 Pharmaceutical Preparations